EUVIMEDOpdag EUVIMED
Scoping ReviewÜbersichtsarbeitOpen access · CC BY 4.0

Hemozoin as a Diagnostic Biomarker: A Scoping Review of Next-Generation Malaria Detection Technologies

Afiat Berbudi iD, Shafia Khairani iD, Alexander Kwarteng iD, Ngozi Mirabel Otuonye iD

Biosensors · 2026

DOI: 10.3390/bios16010048 ↗

At a glance

Scoping Review in Biosensors, 2026. Written by Afiat Berbudi and 3 co-authors. Institution: Department of Biomedical Sciences, Parasitology Division, Faculty of Medicine, Universitas Padjadjaran, Bandung 40161, Indonesia. Major MEDLINE topics: Hemeproteins, Malaria, Biosensing Techniques. Cited 3 times so far (Crossref); 50 references. The full text is freely available (open access, CC BY 4.0). Funded by: Indonesian Endowment Fund for Education (LPDP) of the Ministry of Higher Education, Science, and Technology.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Accurate malaria diagnosis is essential for effective case management and transmission control; however, the sensitivity, operational requirements, and field applicability of current conventional methods are limited. Hemozoin, an optically and magnetically active crystalline biomarker produced by Plasmodium species, offers a reagent-free target for next-generation diagnostics. This scoping review, following PRISMA-ScR and Joanna Briggs Institute guidance, synthesizes recent advances in hemozoin-based detection technologies and maps the current landscape. Twenty-four studies were reviewed, spanning eight major technology classes: magneto-optical platforms, magnetophoretic microdevices, photoacoustic detection, Raman/SERS spectroscopy, optical and hyperspectral imaging, NMR relaxometry, smartphone-based microscopy, and flow cytometry. Magneto-optical systems—including Hz-MOD, Gazelle™, and RMOD—demonstrated the highest operational readiness, with robust specificity but reduced sensitivity at low parasitemia. Photoacoustic Cytophone studies demonstrated promising sensitivity and noninvasive in vivo detection. Raman/SERS platforms achieved sub-100 infected cell/mL analytical sensitivity but remain laboratory-bound. Microfluidic and smartphone-based tools offer emerging, potentially low-cost alternatives. Across modalities, performance varied by parasite stage, with reduced detection of early ring forms. In conclusion, hemozoin-targeted diagnostics represent a rapidly evolving field with multiple viable translational pathways. While magneto-optical devices are closest to field deployment, further clinical validation, improved low-density detection, and standardized comparison across platforms are needed to support future adoption in malaria-endemic settings.

Subjects

MeSH terms (MEDLINE)

HemeproteinsMalariaBiosensing TechniquesHumansBiomarkersSpectrum Analysis, RamanPlasmodiumPhotoacoustic Techniques

Author keywords

biosensing techniqueshemozoin analysismagneticsmalaria diagnosisoptical phenomenapoint-of-care testing

Substances

hemozoinHemeproteinsBiomarkers

Authors and institutions

  • Department of Biomedical Sciences, Parasitology Division, Faculty of Medicine, Universitas Padjadjaran, Bandung 40161, Indonesia.
  • Research Center for Care and Control of Infectious Diseases (RC3ID), Universitas Padjadjaran, Bandung 40161, Indonesia.
  • Department of Biomedical Sciences, Cell Biology Division, Faculty of Medicine, Universitas Padjadjaran, Bandung 40161, Indonesia.
  • Veterinary Medicine Program, Faculty of Medicine, Universitas Padjadjaran, Sumedang 45363, Indonesia.
  • Department of Biochemistry and Biotechnology, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Central Research Laboratory, Nigerian Institute of Medical Research, Yaba, Lagos P.O. Box P.M.B. 2013, Nigeria.

ORCID profiles: Afiat Berbudi, Shafia Khairani, Alexander Kwarteng, Ngozi Mirabel Otuonye

Funding

  • Indonesian Endowment Fund for Education (LPDP) of the Ministry of Higher Education, Science, and Technology

Cite

APA

Berbudi, A., Khairani, S., Kwarteng, A., & Otuonye, N. M. (2026). Hemozoin as a Diagnostic Biomarker: A Scoping Review of Next-Generation Malaria Detection Technologies. Biosensors. https://doi.org/10.3390/bios16010048

Vancouver

Berbudi A, Khairani S, Kwarteng A, Otuonye NM. Hemozoin as a Diagnostic Biomarker: A Scoping Review of Next-Generation Malaria Detection Technologies. Biosensors. 2026. doi:10.3390/bios16010048

BibTeX
@article{Berbudi2026,
  author = {Berbudi, Afiat and Khairani, Shafia and Kwarteng, Alexander and Otuonye, Ngozi Mirabel},
  title = {Hemozoin as a Diagnostic Biomarker: A Scoping Review of Next-Generation Malaria Detection Technologies},
  journal = {Biosensors},
  year = {2026},
  doi = {10.3390/bios16010048}
}
Start for free →